Vimarsana
Biggest News Aggregation in the World

Provelmare Holding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Provelmare Holding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Provelmare Holding Today - Breaking & Trending Today

Investegate |Roquefort Investmnts Announcements | Roquefort Investmnts: Publication of Prospectus - Vimarsana News

Investegate |Roquefort Investmnts Announcements | Roquefort Investmnts: Publication of Prospectus

Investegate announcements from Roquefort Investmnts, Publication of Prospectus

Investegate |Roquefort Investmnts Announcements | Roquefort Investmnts: Interim Results to 30 June 2021 - Vimarsana News

Investegate |Roquefort Investmnts Announcements | Roquefort Investmnts: Interim Results to 30 June 2021

Investegate announcements from Roquefort Investmnts, Interim Results to 30 June 2021

Cellmid Ltd receives Chinese import permits for its Jo-Ju® and Lexilis® branded shampoos - Vimarsana News

Cellmid Ltd receives Chinese import permits for its Jo-Ju® and Lexilis® branded shampoos

Cellmid receives Chinese import permits for its Jo-Ju® and Lexilis® branded shampoos The health and beauty-tech business is focused on global distribution and sales of its scientifically validated innovative consumer products. The import permits allow the sale of the shampoo products in any channel in mainland China. Cellmid Ltd (ASX:CDY) has received Chinese import permits for its Jo-Ju® and Lexilis® branded shampoos from the National Medical Products Administration (NMPA). This marks an important milestone in the implementation of the distribution agreement signed in Decembe...

Cellmid Limited signs agreement for sale of biotech subsidiary Lyramid Limited - Vimarsana News

Cellmid Limited signs agreement for sale of biotech subsidiary Lyramid Limited

Cellmid signs agreement for sale of biotech subsidiary Lyramid Limited The company will retain the benefit of future upside with a 4% royalty on product sales by Lyramid (8% on sub-licence income). Cellmid has received a A$500,000 upfront payment. Cellmid Limited (ASK:CDY) has signed a binding agreement with Provelmare Holding SA, a Panama-based company, for the sale of Lyramid Limited, Cellmid's wholly-owned research and development subsidiary focused on commercialising its midkine intellectual property portfolio. Midkine, an important novel therapeutic target, is a growth fact...